{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-08-05",
    "results": {
      "skip": 4400,
      "limit": 1,
      "total": 17866
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Phoenix",
      "state": "AZ",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "86343",
      "recalling_firm": "RLC Labs Inc.",
      "address_1": "1850 E Riverview Dr",
      "address_2": "N/A",
      "postal_code": "85034-6703",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "E-Mail",
      "distribution_pattern": "Nationwide in the United States",
      "recall_number": "D-1608-2020",
      "product_description": "WP Thyroid, Westhroid Pure, 3/4 Grain (48.75 mg) Thyroid USP, packaged in a) 1,000 Tablets, NDC 64727-5650-2 ; b) 30 Tablets, NDC  64727-5650-4; c) 60 Tablets, NDC 64727-5650-5; d) 90 Tablets, NDC 64727-5650-6; e) 100 Tablets, NDC 64727-5650-1; Rx only, Manufactured by: RLC Labs Phoenix, AZ 85034",
      "product_quantity": "N/A",
      "reason_for_recall": "CGMP Deviations: manufactured under the same conditions as those found to be subpotent.",
      "recall_initiation_date": "20200825",
      "center_classification_date": "20200924",
      "termination_date": "20231108",
      "report_date": "20200923",
      "code_info": "All lots with expiry between 10/2020-07/2023"
    }
  ]
}